The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
Global medical polymers demand is expected to reach about 5,156.19 MT by 2015, with estimated market production value of 13,746.84 million USD in the same year. The average gross margin is about 41.47%.
EU is the biggest producers with a market share of 36.99% in 2014, while North Anerica follows it with a market share of 26.98% in the same year.
There are mainly three types of medical polymers- medical resins and fibers, medical elastomers, biodegradable plastics. Medical resins and fibers are the largested type of medical polymers. The production of medical polymers is 4,085.52K MT in 2014 and it shares 81.06% of the whole medical polymers market.

According to this study, over the next five years the Medical Polymers market will register a 3.8% CAGR in terms of revenue, the global market size will reach USD 18900 million by 2024, from USD 15100 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Polymers business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Polymers market by product type, application, key manufacturers and key regions and countries.

This study considers the Medical Polymers value and volume generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Medical resins and fibers
Medical elastomers
Biodegradable plastics
Other
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Medical devices and equipment
Medical packaging
Others (Including tissue engineering and cardio stents)

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
BASF SE
Bayer
Celanese
DSM
Du Pont
Solvay
Eastman Chemical
Evonik
HEXPOL
Exxon Mobil
Formosa Plastics
INEOS
Dow
Victrex
Colorite Compounds
Raumedic
Kraton
Tianjin Plastics
Shanghai New Shanghua

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Medical Polymers consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Medical Polymers market by identifying its various subsegments.
Focuses on the key global Medical Polymers manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Polymers with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Medical Polymers submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.